Logan Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $742K | Sell |
10,747
-10,034
| -48% | -$693K | 0.03% | 218 |
|
|
2025
Q1 | $1.44M | Sell |
20,781
-444
| -2% | -$30.8K | 0.07% | 193 |
|
|
2024
Q4 | $1.83M | Sell |
21,225
-8,188
| -28% | -$704K | 0.08% | 184 |
|
|
2024
Q3 | $3.5M | Sell |
29,413
-117
| -0.4% | -$13.9K | 0.14% | 143 |
|
|
2024
Q2 | $4.22M | Sell |
29,530
-211
| -0.7% | -$30.1K | 0.18% | 125 |
|
|
2024
Q1 | $3.82M | Buy |
29,741
+91
| +0.3% | +$11.7K | 0.16% | 135 |
|
|
2023
Q4 | $3.07M | Sell |
29,650
-38
| -0.1% | -$3.93K | 0.14% | 150 |
|
|
2023
Q3 | $2.7M | Hold |
29,688
| – | – | 0.14% | 149 |
|
|
2023
Q2 | $2.4M | Hold |
29,688
| – | – | 0.12% | 162 |
|
|
2023
Q1 | $2.36M | Sell |
29,688
-222
| -0.7% | -$17.7K | 0.11% | 163 |
|
|
2022
Q4 | $2.02M | Buy |
29,910
+256
| +0.9% | +$17.3K | 0.1% | 170 |
|
|
2022
Q3 | $1.48M | Buy |
29,654
+738
| +3% | +$36.8K | 0.09% | 182 |
|
|
2022
Q2 | $1.61M | Buy |
28,916
+2,992
| +12% | +$167K | 0.09% | 180 |
|
|
2022
Q1 | $1.44M | Sell |
25,924
-888
| -3% | -$49.3K | 0.07% | 190 |
|
|
2021
Q4 | $1.5M | Buy |
26,812
+452
| +2% | +$25.3K | 0.07% | 197 |
|
|
2021
Q3 | $1.27M | Buy |
26,360
+2,808
| +12% | +$135K | 0.06% | 206 |
|
|
2021
Q2 | $986K | Buy |
23,552
+14,334
| +156% | +$600K | 0.05% | 215 |
|
|
2021
Q1 | $311K | Buy |
+9,218
| New | +$311K | 0.02% | 260 |
|